tiprankstipranks
Genix Pharmaceuticals (TSE:GENX)
TSXV:GENX
Canadian Market
Holding TSE:GENX?
Track your performance easily

Genix Pharmaceuticals (GENX) Financial Statements

1 Followers

Genix Pharmaceuticals Financial Overview

Genix Pharmaceuticals's market cap is currently ―. The company's EPS TTM is C$-0.067; its P/E ratio is -0.81; Genix Pharmaceuticals is scheduled to report earnings on March 4, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Jul 24Apr 24Jan 24Oct 23Jul 23
Income Statement-
Total RevenueC$ 999.00C$ 8.08KC$ 71.00-C$ -2.68K
Gross ProfitC$ 641.00C$ 189.00C$ 58.00-C$ -3.12K
EBITC$ -49.45KC$ -225.05KC$ -35.16KC$ -3.76MC$ -217.29K
EBITDAC$ -49.16KC$ -224.77KC$ -34.88KC$ -3.62MC$ -81.37K
Net Income Common StockholdersC$ -82.17KC$ -234.02KC$ -59.06KC$ -3.77MC$ -227.38K
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 10.23KC$ 9.55KC$ 9.30KC$ 11.63KC$ 4.24K
Total AssetsC$ 232.78KC$ 247.37KC$ 246.70KC$ 223.46KC$ 3.84M
Total DebtC$ 739.34KC$ 660.90KC$ 575.39KC$ 511.52KC$ 420.64K
Net DebtC$ 729.11KC$ 651.36KC$ 566.09KC$ 499.89KC$ 416.40K
Total LiabilitiesC$ 1.60MC$ 1.53MC$ 1.44MC$ 1.36MC$ 1.27M
Stockholders EquityC$ -1.36MC$ -1.28MC$ -1.20MC$ -1.14MC$ 2.57M
Cash Flow-
Free Cash FlowC$ -45.93KC$ -58.50KC$ -42.56KC$ -60.55KC$ -52.83K
Operating Cash FlowC$ -45.93KC$ -58.50KC$ -42.56KC$ -60.55KC$ -52.83K
Investing Cash Flow-----
Financing Cash FlowC$ 46.62KC$ 58.75KC$ 40.23KC$ 67.95KC$ 16.71K
Currency in CAD

Genix Pharmaceuticals Earnings and Revenue History

Genix Pharmaceuticals Debt to Assets

Genix Pharmaceuticals Cash Flow

Genix Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis